Exact Mass: 361.2033

Exact Mass Matches: 361.2033

Found 153 metabolites which its exact mass value is equals to given mass value 361.2033, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4-Hydroxydecanedioylcarnitine

3-[(9-carboxy-4-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


4-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxydecanedioylcarnitine

3-[(9-carboxy-3-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


3-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxydecanedioylcarnitine

3-[(9-carboxy-5-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


5-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octocrylene

2-Ethylhexyl 2-cyano-3,3-diphenylprop-2-enoic acid

C24H27NO2 (361.2042)


C1892 - Chemopreventive Agent > C851 - Sunscreen

   

Semagacestat

2-Hydroxy-3-methyl-N-{1-[(3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl)-C-hydroxycarbonimidoyl]ethyl}butanimidate

C19H27N3O4 (361.2001)


   

Bacithrocin C 2

Bacithrocin C 2

C18H27N5O3 (361.2114)


   

Octocrylene

Octocrylene

C24H27NO2 (361.2042)


C1892 - Chemopreventive Agent > C851 - Sunscreen CONFIDENCE standard compound; INTERNAL_ID 2501 CONFIDENCE standard compound; INTERNAL_ID 8141 CONFIDENCE standard compound; EAWAG_UCHEM_ID 229

   

Murrayamine F

Murrayamine F

C24H27NO2 (361.2042)


   

beta-Methoxy-Mahanimbicine|Murrayamine-C

beta-Methoxy-Mahanimbicine|Murrayamine-C

C24H27NO2 (361.2042)


   

Murrayamine H

Murrayamine H

C24H27NO2 (361.2042)


   

Murrayamine B

Murrayamine B

C24H27NO2 (361.2042)


   

O-Methylmahanine

O-Methylmahanine

C24H27NO2 (361.2042)


   
   
   
   
   
   

glutaminylseryllysine

glutaminylseryllysine

C14H27N5O6 (361.1961)


   
   
   
   

asparagylthreonyllysine

asparagylthreonyllysine

C14H27N5O6 (361.1961)


   
   
   
   
   
   
   

threonylasparagyllysine

threonylasparagyllysine

C14H27N5O6 (361.1961)


   
   
   
   
   
   
   

Ala Gly Lys Ser

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-aminopropanamido]acetamido}hexanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Ala Gly Ser Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxypropanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Ala Lys Gly Ser

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]acetamido}-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Ala Lys Ser Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxypropanamido]acetic acid

C14H27N5O6 (361.1961)


   

Ala Ser Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]acetamido}hexanoic acid

C14H27N5O6 (361.1961)


   

Ala Ser Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]hexanamido]acetic acid

C14H27N5O6 (361.1961)


   

Gly Ala Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)propanamido]hexanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Gly Ala Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxypropanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Gly Gly Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]-3-hydroxybutanoic acid

C14H27N5O6 (361.1961)


   

Gly Gly Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[2-(2-aminoacetamido)acetamido]-3-hydroxybutanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Gly Lys Ala Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]propanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Gly Lys Gly Thr

(2S,3R)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}-3-hydroxybutanoic acid

C14H27N5O6 (361.1961)


   

Gly Lys Ser Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxypropanamido]propanoic acid

C14H27N5O6 (361.1961)


   

Gly Lys Thr Gly

2-[(2S,3R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxybutanamido]acetic acid

C14H27N5O6 (361.1961)


   

Gly Ser Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]propanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Gly Ser Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]hexanamido]propanoic acid

C14H27N5O6 (361.1961)


   

Gly Thr Gly Lys

(2S)-6-amino-2-{2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]acetamido}hexanoic acid

C14H27N5O6 (361.1961)


   

Gly Thr Lys Gly

2-[(2S)-6-amino-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]hexanamido]acetic acid

C14H27N5O6 (361.1961)


   
   

Lys Ala Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]acetamido}-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Lys Ala Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxypropanamido]acetic acid

C14H27N5O6 (361.1961)


   

Lys Gly Ala Ser

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}propanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961)


   

Lys Gly Gly Thr

(2S,3R)-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)-3-hydroxybutanoic acid

C14H27N5O6 (361.1961)


   

Lys Gly Ser Ala

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxypropanamido]propanoic acid

C14H27N5O6 (361.1961)


   

Lys Gly Thr Gly

2-[(2S,3R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxybutanamido]acetic acid

C14H27N5O6 (361.1961)


   

Lys Ser Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]acetic acid

C14H27N5O6 (361.1961)


   

Lys Ser Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]acetamido}propanoic acid

C14H27N5O6 (361.1961)


   

Lys Thr Gly Gly

2-{2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]acetamido}acetic acid

C14H27N5O6 (361.1961)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Ser Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]acetamido}hexanoic acid

C14H27N5O6 (361.1961)


   

Ser Ala Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]hexanamido]acetic acid

C14H27N5O6 (361.1961)


   
   

Ser Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}propanamido]hexanoic acid

C14H27N5O6 (361.1961)


   

Ser Gly Lys Ala

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}hexanamido]propanoic acid

C14H27N5O6 (361.1961)


   
   

Ser Lys Ala Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]propanamido]acetic acid

C14H27N5O6 (361.1961)


   

Ser Lys Gly Ala

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]acetamido}propanoic acid

C14H27N5O6 (361.1961)


   
   

Thr Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}acetamido)hexanoic acid

C14H27N5O6 (361.1961)


   

Thr Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}hexanamido]acetic acid

C14H27N5O6 (361.1961)


   

Thr Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]acetamido}acetic acid

C14H27N5O6 (361.1961)


   

Levophenacylmorphan

Levophenacylmorphan

C24H27NO2 (361.2042)


   

2-Bromo-N-hexadecylacetamide

2-Bromo-N-hexadecylacetamide

C18H36BrNO (361.198)


   

4-Cyanophenyl trans-4-(4-butylcyclohexyl)benzoate

4-Cyanophenyl trans-4-(4-butylcyclohexyl)benzoate

C24H27NO2 (361.2042)


   

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

C19H28BNO5 (361.206)


   

Semagacestat

Semagacestat(LY450139)

C19H27N3O4 (361.2001)


D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Tert-Butyl(S)-1-((S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino)-1-oxopropan-2-ylcarbamate

Tert-Butyl(S)-1-((S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino)-1-oxopropan-2-ylcarbamate

C19H27N3O4 (361.2001)


   

Dapiprazole Hydrochloride

Dapiprazole Hydrochloride

C19H28ClN5 (361.2033)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants Dapiprazole hydrochloride is a potent, selective and orally active alpha-1 adrenoceptor antagonist. Dapiprazole hydrochloride suppresses the opioid withdrawal symptoms. Dapiprazole hydrochloride is also used as eye drops for reversing mydriasis[1][2][3].

   

Pharmakon1600-01506187

Pharmakon1600-01506187

C24H27NO2 (361.2042)


   

(6R)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclo

(6R)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclo

C21H29O5- (361.2015)


   

(4R)-4,5-dihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)-3-oxocyclohexa-1,5-dien-1-olate

(4R)-4,5-dihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)-3-oxocyclohexa-1,5-dien-1-olate

C21H29O5- (361.2015)


   
   

4-Hydroxydecanedioylcarnitine

4-Hydroxydecanedioylcarnitine

C17H31NO7 (361.21)


   

3-Hydroxydecanedioylcarnitine

3-Hydroxydecanedioylcarnitine

C17H31NO7 (361.21)


   

5-Hydroxydecanedioylcarnitine

5-Hydroxydecanedioylcarnitine

C17H31NO7 (361.21)


   
   
   
   
   
   
   

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

N-[[(2R,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

N-[[(2S,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2S,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

N-[[(2R,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

4-(2-Butanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(2-Butanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


   

4-(3-Acetyloxy-2-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Acetyloxy-2-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21)


   

6-methoxy-13,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

6-methoxy-13,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

C24H27NO2 (361.2042)


   

9-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

9-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

9-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

9-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

10-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

10-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

(3r)-10-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

(3r)-10-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

(3r)-9-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

(3r)-9-methoxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

(2s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-[(1-hydroxypropylidene)amino]-3-phenylpropanimidic acid

(2s)-n-(5-carbamimidamido-1-oxopentan-2-yl)-2-[(1-hydroxypropylidene)amino]-3-phenylpropanimidic acid

C18H27N5O3 (361.2114)


   

10-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

10-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

(3s)-10-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

(3s)-10-methoxy-3,8-dimethyl-3-(4-methylpent-3-en-1-yl)-11h-pyrano[3,2-a]carbazole

C24H27NO2 (361.2042)


   

6-methoxy-8,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

6-methoxy-8,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

C24H27NO2 (361.2042)